BENGALURU: The Karnataka High Court appointed the wife of a retired man as his guardian to operate his three savings bank ...

The indie singer-songwriter announced his diagnosis in 2023 with a photo of himself in a wheelchair Sufjan Stevens gave a ...

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome ...

The GBS | CIDP Foundation International is making strides to increase awareness of Guillain-Barré Syndrome (GBS), Chronic ...

The technology has gradually helped Maynard get closer to her ultimate goal — reaching total independence and returning to ...

Of the RSV patients aged 60 or older, 23.0% were admitted to an ICU, 31.5% had acute organ failure, and 9.8% received IMV or ...

The Move GBS Forward campaign highlights a promising new approach to treatment of the disease. Annexon Biosciences CEO Doug ...

FDA Meeting for Tanruprubart (formerly ANX005), the First Potential Targeted Therapy for GBS, Scheduled for Second Quarter 2025 Ahead of Planned BLA Submission Open-Label Tanruprubart FORWARD Study ...

Pune: A seven-and-half-year-old boy was discharged from Deenanath Mangeshkar Hospital on May 3 after battling a ...

The GBS | CIDP Foundation International is commemorating Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy Awareness Month this May by launching a global campaign to raise ...

Patients who are immunocompromised still can receive a variety of vaccinations based on their specific needs, Cassandra ...